SFM
MDCO

Sphera Funds Management’s Medicines Co MDCO Stock Holding History

Sphera Funds Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,000
Closed -$2.86M – 153
2015
Q2 		$2.86M Hold
1,000
– – 0.28% 94
2015
Q1 		$2.8M Buy
+1,000
New +$28.1K 0.29% 87

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sphera Funds Management's MDCO Position: Q1 2016 in Review

Sphera Funds Management sold out of Medicines Co (MDCO) in Q1 2016, closing a stake of 60,000 shares — an estimated $2.24M sold.

Sphera Funds Management first reported a position in MDCO in Q4 2013 and held it in 5 quarters. The position peaked at $5.15M in Q2 2015. 181 funds tracked by Wall St. Rank hold MDCO as of Q1 2016.

  • Sphera Funds Management reported no remaining Medicines Co position as of Q1 2016 after selling out during the quarter.
  • Sphera Funds Management sold 60,000 Medicines Co shares in Q1 2016, an estimated $2.24M.
  • Sphera Funds Management first reported a position in Medicines Co in Q4 2013 and held it in 5 quarters.
  • Sphera Funds Management's Medicines Co position peaked at $5.15M in Q2 2015.
  • 181 funds tracked by Wall St. Rank held Medicines Co as of Q1 2016.

Based on Sphera Funds Management's 13F filing for Q1 2016, filed 16 May 2016.